Latest period
$1.54B
YoY change
+8.9%
5Y CAGR
+0.7%
Peak year (2021)
$2.52B
Cumulative CapEx
$19.13B
CapEx history chart for Thermo Fisher Scientific (TMO) from 1989 to 2025
Latest: $1.52B
CapEx growth chart for Thermo Fisher Scientific (TMO) from 1989 to 2025
Latest: +8.9%
CapEx history table for Thermo Fisher Scientific (TMO) from 1989 to 2025
| 2025 | $1.52B | +8.9% | +$125.00M | ||
| 2024 | $1.40B | -5.3% | −$79.00M | ||
| 2023 | $1.48B | -34.1% | −$764.00M | ||
| 2022 | $2.24B | -11.1% | −$280.00M | ||
| 2021 | $2.52B | +71.2% | +$1.05B | ||
| 2020 | $1.47B | +59.2% | +$548.00M | ||
| 2019 | $926.00M | +22.2% | +$168.00M | ||
| 2018 | $758.00M | +49.2% | +$250.00M | ||
| 2017 | $508.00M | +14.3% | +$63.60M | ||
| 2016 | $444.40M | +5.1% | +$21.50M | ||
| 2015 | $422.90M | -1.1% | −$4.70M | ||
| 2014 | $427.60M | +51.4% | +$145.20M | ||
| 2013 | $282.40M | -10.4% | −$32.70M | ||
| 2012 | $315.10M | +18.2% | +$48.60M | ||
| 2011 | $266.50M | +0.4% | +$1.00M | ||
| 2010 | $265.50M | +28.0% | +$58.00M | ||
| 2009 | $207.50M | -21.5% | −$56.90M | ||
| 2008 | $264.40M | +50.7% | +$88.90M | ||
| 2007 | $175.50M | +128.5% | +$98.70M | ||
| 2006 | $76.80M | +76.4% | +$33.25M | ||
| 2005 | $43.55M | -12.9% | −$6.44M | ||
| 2004 | $49.98M | +8.3% | +$3.85M | ||
| 2003 | $46.14M | -9.9% | −$5.08M | ||
| 2002 | $51.21M | -39.6% | −$33.59M | ||
| 2001 | $84.80M | +14.5% | +$10.76M | ||
| 2000 | $74.04M | -84.8% | −$413.96M | ||
| 1999 | $488.00M | +21.6% | +$86.80M | ||
| 1998 | $401.20M | -58.2% | −$559.50M | ||
| 1997 | $960.70M | +671.6% | +$836.20M | ||
| 1996 | $124.50M | +97.9% | +$61.60M | ||
| 1995 | $62.90M | +4.5% | +$2.70M | ||
| 1994 | $60.20M | +6.4% | +$3.60M | ||
| 1993 | $56.60M | -5.7% | −$3.40M | ||
| 1992 | $60.00M | +79.1% | +$26.50M | ||
| 1991 | $33.50M | -72.1% | −$86.50M | ||
| 1990 | $120.00M | +150.5% | +$72.10M | ||
| 1989 | $47.90M | — | — |
- 2025$1.52B+8.9%
- 2024$1.40B-5.3%
- 2023$1.48B-34.1%
- 2022$2.24B-11.1%
- 2021$2.52B+71.2%
- 2020$1.47B+59.2%
- 2019$926.00M+22.2%
- 2018$758.00M+49.2%
- 2017$508.00M+14.3%
- 2016$444.40M+5.1%
- 2015$422.90M-1.1%
- 2014$427.60M+51.4%
- 2013$282.40M-10.4%
- 2012$315.10M+18.2%
- 2011$266.50M+0.4%
- 2010$265.50M+28.0%
- 2009$207.50M-21.5%
- 2008$264.40M+50.7%
- 2007$175.50M+128.5%
- 2006$76.80M+76.4%
- 2005$43.55M-12.9%
- 2004$49.98M+8.3%
- 2003$46.14M-9.9%
- 2002$51.21M-39.6%
- 2001$84.80M+14.5%
- 2000$74.04M-84.8%
- 1999$488.00M+21.6%
- 1998$401.20M-58.2%
- 1997$960.70M+671.6%
- 1996$124.50M+97.9%
- 1995$62.90M+4.5%
- 1994$60.20M+6.4%
- 1993$56.60M-5.7%
- 1992$60.00M+79.1%
- 1991$33.50M-72.1%
- 1990$120.00M+150.5%
- 1989$47.90M—
CapEx values are taken from Thermo Fisher Scientific's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's current CapEx (TTM) is $1.54B. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Thermo Fisher Scientific (TMO) CapEx totalled $1.52B – grew 8.9% year-over-year.
Thermo Fisher Scientific CapEx has grown on net over the period, with a +0.7% compound annual growth rate over 2020–2025 (5 years).
Thermo Fisher Scientific CapEx plunged from $2.52B in 2021 to $1.52B in 2025, a 39.6% drawdown.
The record annual CapEx stands at $2.52B, reached in 2021; the historical low of $33.50M was recorded in 1991.
Thermo Fisher Scientific Capital Expenditures by Year
Thermo Fisher Scientific Capital Expenditures 2025: $1.52B
2025's CapEx for Thermo Fisher Scientific came in at $1.52B, grew 8.9% from 2024.
Thermo Fisher Scientific Capital Expenditures 2024: $1.40B
Thermo Fisher Scientific posted CapEx of $1.40B in 2024, declined 5.3% below 2023.
Thermo Fisher Scientific Capital Expenditures 2023: $1.48B
In 2023, Thermo Fisher Scientific reported CapEx of $1.48B, plunged 34.1% below 2022.
Thermo Fisher Scientific Capital Expenditures 2022: $2.24B
Thermo Fisher Scientific CapEx in 2022 was $2.24B, declined 11.1% below 2021.
Thermo Fisher Scientific Capital Expenditures 2021: $2.52B
Thermo Fisher Scientific CapEx in 2021 was $2.52B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers by CapEx
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation